Filter Results:
(610)
Show Results For
- All HBS Web
(610)
- People (4)
- News (110)
- Research (426)
- Events (3)
- Multimedia (4)
- Faculty Publications (259)
Show Results For
- All HBS Web
(610)
- People (4)
- News (110)
- Research (426)
- Events (3)
- Multimedia (4)
- Faculty Publications (259)
- 01 Dec 1998
- News
Novartis AG Establishes Global Research Fund
Four HBS professors whose international research efforts range from biotechnology in Taiwan to foreign investments in Costa Rica have been named the first Novartis Faculty Fellows. The two-year fellowships, funded by a $2 million gift from the worldwide View Details
Keywords: Anne Kavanagh
Charles H. Revson
Known for his autocratic and direct management style, Revson built Revlon into the second largest cosmetics company in the U.S. Revson's unique talent of grasping the female psyche, bolstered by his fiercely competitive nature, allowed... View Details
Keywords: Personal Care & Home Products
- 01 Dec 2004
- News
Finding a Balance
Do the rules of business change when a company’s product holds the power of life or death over its customers? That’s a question students must consider when discussing “Cipla,” a case about a $325 million Indian pharmaceutical View Details
Charles A. Heimbold, Jr.
Heimbold focused on Bristol-Myers Squibb’s growth and created a scientific-based, world-leading pharmaceutical company with very strong consumer franchises. Sixty-two percent of its sales come from View Details
Keywords: Healthcare
- 11 Sep 2019
- Research & Ideas
Germany May Have the Answer for Reducing Drug Prices
the Poronui Associate Professor of Business Administration. Pharmaceutical companies have long opposed efforts to regulate drug prices, arguing that prices reflect the companies’ massive research... View Details
- 08 Jun 2021
- News
New Funding for Female Founders
Boost VC, SV Angel, Village Global, and Threshold Ventures, according to the Wall Street Journal. Coravos is co-founder and CEO of the startup, formerly known as Elektra Labs, which helps hospitals and pharmaceutical View Details
- 03 Dec 2001
- Research & Ideas
Healthcare Conference Looks At Ailing Industry
lumped together because they have the same mechanism, although they may look different to us, he said. What this portends commercially is up to smart companies to figure out, he said. Companies will need the... View Details
- 19 Sep 2017
- First Look
First Look at New Research and Ideas, September 19
717-426 Imprimis (A) This case examines the strategic choices and evolving business model of Imprimis Pharmaceuticals from the perspective of CEO Mark Baum. The (A) case provides a brief history of the View Details
Keywords: Sean Silverthorne
Steve Cagnetta
pharmaceutical and medical device companies. From time to time, he has represented and advised venture and angel groups on various matters. Prior to founding Company Counsel, Steve practiced at Hutchins,... View Details
- 24 Apr 2014
- News
Building a better India through business and philanthropy
Known for understanding opportunities ahead of the curve, Ajay Piramal (AMP 110, 1992) led his family’s business away from textiles to pharmaceuticals in the 1980s. “Our guiding principle has been to build businesses that deliver... View Details
- 01 Sep 2008
- News
Mara Aspinall
that personalized medicine brings. This is particularly important in fast-moving diseases, where the window for a positive outcome is small. What aspects of their business model do pharmaceutical companies... View Details
Josiah K. Lilly
Lilly, a trained pharmacist and the founder of the family drug manufacturer, set up the first scientific division in the company and focused on standards of manufacturing and scientific development. Among other products, the View Details
Keywords: Healthcare
- Fast Answer
Investing in Life Sciences - SIP Resources
email address. Reports will be sent via email within one business day. Company screening, how to create a target list: PE & VC investors by investment criteria (industry, stage and geography) Startups: venture-backed, by... View Details
- 01 Dec 1996
- News
New Releases
a competitive factor. In a three-year study of pharmaceutical and biotechnology firms, Pisano shows that the development of distinctive and superior process technologies can lower costs, improve quality, and increase flexibility. He... View Details
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
executive branch and in Congress—who lacked the courage to risk political damage and take a stand on the issue. Sometimes, leaders actually set themselves up for predictable surprises. A classic example is the 1998 decision by a coalition of thirty-nine View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- 15 Dec 2024
- News
After Ozempic
Back before Ozempic, when Kate Mulroney (MBA 1984) spoke at technical conferences about her work at Novo Nordisk, people often assumed she was talking about Novartis. “I’d have to explain that’s a Swiss company; we’re Danish,” says Mulroney, now head of advanced... View Details
- 06 Feb 2007
- First Look
First Look: February 6, 2007
http://www.hbsp.harvard.edu/b01/en/common/item_detail.jhtml?id=806092 Endo Pharmaceuticals (A): From LBO to...? Harvard Business School Case 806-064 Endo Pharmaceuticals was formed in 1997 as a leveraged... View Details
Keywords: Martha Lagace
Arjun Goyal
Dr. Arjun Goyal is a Co-Founder and Managing Director of Vida Ventures, a leading US-based life sciences venture capital firm with a ~$1.8 billion in AUM. Arjun focuses on creating and investing in companies that translate groundbreaking... View Details
Keywords: Finance
Arjun Goyal
Dr. Arjun Goyal is a Co-Founder and Managing Director of Vida Ventures, a leading US-based life sciences venture capital firm with approximately $1.7 billion in AUM. Arjun focuses on creating and investing in companies that translate... View Details
- 25 Jun 2020
- News
Covering All Corners
Riad Armanious (MBA 2008) regards the pandemic as the greatest professional challenge he has faced as managing director of family-owned Eva Group and CEO of Eva Pharma, a multinational pharmaceutical company... View Details